Thyroid Carcinoma Primary Differentiated: Clinical Trials

1 trial for Thyroid Carcinoma Primary Differentiated, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Not yet recruiting 1

Follow Thyroid Carcinoma Primary Differentiated: new trials by email Literature Review of Thyroid Carcinoma Primary Differentiated trials Research Report on Thyroid Carcinoma Primary Differentiated

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of ACC-1898 in Adult Participants With Advanced Solid Tumors
ACC-1898 - Hepatocellular Carcinoma, Renal Cell Carcinoma
Phase 1Not yet recruitingAccSalus Biosciences, Inc.402026-01-012025-11-28

Narrower conditions

Carcinoma, Hepatocellular (1)  ·  Carcinoma, Renal Cell (1)  ·  Gallbladder Neoplasms (1)  ·  Melanoma (1)  ·  Neoplasm Metastasis (1)  ·  Thyroid cancer, medullary (1)

Broader conditions

Adenocarcinoma (1)  ·  Biliary Tract Diseases (1)  ·  Biliary Tract Neoplasms (1)  ·  Carcinoma (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Gallbladder Diseases (1)  ·  Kidney Diseases (1)  ·  Kidney Neoplasms (1)  ·  Liver Diseases (1)  ·  Liver Neoplasms (1)  ·  Male Urogenital Diseases (1)  ·  Neoplasms (1)

Interventions

3-(3'-adamantan-1-yl-4'-methoxybiphenyl-4-yl)-2-propenoic acid (1)

Sponsors

AccSalus Biosciences, Inc. (1)